Chairperson: To be advised

Members:

• At least 3 HTC Directors (AHCDO Director Members)

• AHCDO Executive Officer

• AHCDO ABDR Research Fellow

• HFA Executive Director

• HFA Policy and Education Manager

• 1 - 2 ABDR Data Managers Group (DMG) representatives

• 1 - 2 Australian Haemophilia Nurses Group (AHNG) representatives

• 1 - 2 Australia New Zealand Haemophilia Psychosocial Group (ANZHPG) representatives

• 1 - 2 Australian and New Zealand Physiotherapy Haemophilia Group (ANZPHG) representatives

• 1 - 2 HTC pharmacists involved in gene therapy or clinical trials to be nominated by the HTC Director

• 1 - 2 laboratory managers involved in gene therapy or clinical trials to be nominated by the HTC DirectorThe AHCDO

  The Gene and Emerging Therapies Committee (GETS) meets every second month.

  Gene and Emerging Therapies Subcommittee (GETS) Terms of Reference

  Please contact AHCDO Executive Officer for any further information.